AQR Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
195,383
+163,392
| +511% | +$148K | ﹤0.01% | 3077 |
|
|
2025
Q1 | $14.4K | Buy |
+31,991
| New | +$14.4K | ﹤0.01% | 3136 |
|
|
2022
Q1 | – | Sell |
-40,688
| Closed | -$100K | – | 2253 |
|
|
2021
Q4 | $100K | Sell |
40,688
-60,239
| -60% | -$148K | ﹤0.01% | 2148 |
|
|
2021
Q3 | $254K | Buy |
+100,927
| New | +$254K | ﹤0.01% | 2086 |
|
|
2016
Q2 | – | Sell |
-11,713
| Closed | -$29K | – | 2236 |
|
|
2016
Q1 | $29K | Sell |
11,713
-31,390
| -73% | -$77.7K | ﹤0.01% | 2202 |
|
|
2015
Q4 | $143K | Sell |
43,103
-16,050
| -27% | -$53.2K | ﹤0.01% | 2191 |
|
|
2015
Q3 | $143K | Buy |
59,153
+5,509
| +10% | +$13.3K | ﹤0.01% | 2103 |
|
|
2015
Q2 | $157K | Buy |
+53,644
| New | +$157K | ﹤0.01% | 2132 |
|